MedTrace Logo

Safety of Cultured Autologous Adult Adipose Derived Mesenchymal Stem Cell Intravenous Infusion for CP

NCT05018871 · Status: SUSPENDED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2025-04-17

No results posted yet for this study

Summary

This trial will study the safety and efficacy of intravenous infusion of cultured autologous adult adipose derived mesenchymal stem cells for the treatment of Cerebral Palsy

Conditions

  • Cerebral Palsy

Interventions

BIOLOGICAL

autologous adipose derived mesenchymal stem cells

cultured autologous adult adipose derived mesenchymal stem cells

Sponsors & Collaborators

  • The Foundation for Orthopaedics and Regenerative Medicine

    lead OTHER

Principal Investigators

  • Chadwick Prodromos, MD · The Foundation for Orthopaedics and Regenerative Medicine

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-12-31
Primary Completion
2028-12-31
Completion
2028-12-31

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05018871 on ClinicalTrials.gov